← The Wire
NERVNasdaq
Minerva Neurosciences, Inc.
Pharmaceutical Preparations · MA · CIK 1598646
Minerva Neurosciences, Inc. develops and seeks regulatory approval for roluperidone and other potential product candidates
red 8-K · 90d
$210M
Market cap
$5.43
Last close
+24.3%
1D
+16.5%
5D
380K
Volume
Price · last 39 sessions-14.2%
May 4L $4.11 · H $6.33Jun 29
234
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KSecurity-Holder Rights · Bylaw AmendmentJun 4, 20268-KMaterial Agreement · Company UpdateMay 27, 2026424B5424B5May 27, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 23, 2026DEF 14ADEF 14AApr 23, 20268-KCompany UpdateApr 6, 20268-KExecutive Change · Reg FD DisclosureApr 2, 202610-K10-KMar 11, 20268-KResults of OperationsMar 11, 20268-KReg FD Disclosure · Company UpdateFeb 3, 2026SC 13D/ASC 13D/ADec 30, 20258-KExecutive Change · Shareholder VoteDec 22, 2025DEF 14ADEF 14ANov 24, 20258-KExecutive Change · Reg FD DisclosureNov 19, 202510-Q10-QNov 5, 20258-KMaterial Agreement · Equity IssuanceOct 22, 202510-Q10-QAug 14, 202510-Q10-QMay 13, 202510-K/A10-K/AApr 29, 202510-K/A10-K/AApr 21, 20258-KCompany UpdateMar 19, 202510-K10-KFeb 25, 20258-KCompany UpdateJan 13, 20258-KShareholder VoteDec 5, 202410-Q10-QNov 5, 2024DEFA14ADEFA14AOct 22, 2024DEF 14ADEF 14AOct 22, 20248-KDelisting NoticeOct 11, 20248-KCompany UpdateSep 16, 202410-Q10-QAug 6, 20248-KExecutive ChangeMay 30, 202410-Q10-QMay 1, 202410-K/A10-K/AApr 22, 20248-KDelisting NoticeApr 12, 20248-KCompany UpdateFeb 27, 202410-K/A10-K/AFeb 26, 202410-K10-KFeb 22, 2024SC 13GSC 13GFeb 9, 202410-Q10-QNov 7, 20238-KShareholder VoteSep 28, 2023DEFA14ADEFA14AAug 15, 2023DEF 14ADEF 14AAug 15, 202310-Q10-QAug 1, 2023SC 13DSC 13DJul 7, 20238-KMaterial Agreement · Equity IssuanceJun 28, 20238-KCompany UpdateJun 20, 20238-KDelisting NoticeJun 2, 202310-Q10-QMay 15, 20238-KExecutive ChangeMay 5, 20238-KCompany UpdateMay 1, 202310-K/A10-K/AApr 20, 202310-K10-KMar 8, 20238-KCompany UpdateDec 28, 20228-KExecutive ChangeDec 16, 20228-KDelisting NoticeDec 2, 202210-Q10-QNov 9, 20228-KCompany UpdateOct 17, 20228-KDelisting NoticeSep 9, 2022SC 13GSCHEDULE 13GAug 23, 20228-KCompany UpdateAug 22, 202210-Q10-QAug 9, 20228-KBylaw AmendmentJun 17, 20228-KShareholder VoteJun 15, 202210-Q10-QMay 4, 2022DEFA14ADEFA14AApr 26, 2022DEF 14ADEF 14AApr 26, 20228-KReg FD DisclosureApr 13, 20228-KCompany UpdateApr 7, 20228-KDelisting NoticeMar 14, 202210-K10-KMar 1, 20228-KCompany UpdateFeb 28, 20228-KDelisting NoticeJan 18, 20228-KReg FD DisclosureJan 5, 20228-KReg FD DisclosureDec 8, 2021SC 13GUNTERSCHREITUNGNov 24, 2021SC 13GUEBERSCHREITUNGNov 24, 202110-Q10-QNov 8, 20218-KCompany UpdateNov 3, 2021
Similar companies
Comparable business profile · signals at a glance